Paper · 36200073

Non-lysine ubiquitylation: Doing things differently.

Kelsall IR. Front Mol Biosci, 2022. Cited by 62 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Non-lysine ubiquitylation: Doing things differently. Papers, record 36200073. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36200073

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Non-lysine ubiquitylation: Doing things differently.; PubMed
Journal: Front Mol Biosci; PubMed
Year: 2022; PubMed
Publication types: Journal Article, Review; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/36200073/; PubMed
DOI: https://doi.org/10.3389/fmolb.2022.1008175; PubMed
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC9527308/; PubMed
The journal: https://conductscience.org/library/journal-index/101653173; PubMed
Citations, by iCite: 62; iCite
Relative citation ratio, by iCite: 4.31; iCite
Revised in PubMed: 2026-09-05; PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	Kind	ORCID iD
1	Kelsall IR	Ian R

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes it	Agency	Country	NIH project	Stated by
	Wellcome Trust	United Kingdom		PubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References334

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	32,677,670	Chain reactions: molecular mechanisms of RBR ubiquitin ligases.	Biochem Soc Trans	2020	https://conductscience.org/library/papers/32677670	PubMed
2	15,138,260	Transforming growth factor-beta stimulates p300-dependent RUNX3 acetylation, which inhibits ubiquitination-mediated degradation.	J Biol Chem	2004	https://conductscience.org/library/papers/15138260	PubMed
3	23,624,058	Glycogenic activity of R6, a protein phosphatase 1 regulatory subunit, is modulated by the laforin-malin complex.	Int J Biochem Cell Biol	2013	https://conductscience.org/library/papers/23624058	PubMed
4	1,326,082	The Pas2 protein essential for peroxisome biogenesis is related to ubiquitin-conjugating enzymes.	Nature	1992	https://conductscience.org/library/papers/1326082	PubMed
5	24,141,947	Structural basis for ligase-specific conjugation of linear ubiquitin chains by HOIP.	Nature	2013	https://conductscience.org/library/papers/24141947	PubMed
6	23,266,961	Refined preparation and use of anti-diglycine remnant (K-ε-GG) antibody enables routine quantification of 10,000s of ubiquitination sites in single proteomics experiments.	Mol Cell Proteomics	2013	https://conductscience.org/library/papers/23266961	PubMed
7	25,686,088	Structures of CYLD USP with Met1- or Lys63-linked diubiquitin reveal mechanisms for dual specificity.	Nat Struct Mol Biol	2015	https://conductscience.org/library/papers/25686088	PubMed
8	24,865,146	Distribution of protein poly(ADP-ribosyl)ation systems across all domains of life.	DNA Repair (Amst)	2014	https://conductscience.org/library/papers/24865146	PubMed
9	35,585,066	Deubiquitinating enzymes and the proteasome regulate preferential sets of ubiquitin substrates.	Nat Commun	2022	https://conductscience.org/library/papers/35585066	PubMed
10	35,221,561	Scaling skin and failing heart: the cardio-cutaneous connection.	Indian J Thorac Cardiovasc Surg	2022	https://conductscience.org/library/papers/35221561	PubMed

1 to 10 of 334

See all 334 references

Cited by49

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 62 citations.

PMID	Title	Journal	Year	In Papers	Source
42,928,854	When absence becomes functional: lysine deserts in protein regulation and evolution.	Front Mol Biosci	2026	https://conductscience.org/library/papers/42928854	PubMed
42,573,689	UbiSite Approach: Global Site-Specific Profiling of Canonical and Non-Canonical Ubiquitination in Cells and Tissues.	Methods Mol Biol	2026	https://conductscience.org/library/papers/42573689	PubMed
42,566,480	Proteasome-dependent cytoskeleton disruption during Leptospira interrogans infection induces aberrant collective cell migration.	PLoS Pathog	2026	https://conductscience.org/library/papers/42566480	PubMed
42,283,083	Ubiquitin beyond the proteome: lipids, glycans, metabolites, nucleic acids, and an expanding molecular landscape.	Biochem Soc Trans	2026	https://conductscience.org/library/papers/42283083	PubMed
42,165,628	Post-Translational Control of TaFT1 by WAPO1 Ubiquitination Shapes Spike Architecture and Yield in Wheat.	Plant Biotechnol J	2026	https://conductscience.org/library/papers/42165628	PubMed
42,074,047	Fine-Tuning Protein Fate: Mechanisms of E1, E2, and E3 Enzymes and Deubiquitinases in Cell Signaling.	Int J Mol Sci	2026	https://conductscience.org/library/papers/42074047	PubMed
42,053,873	Ubiquitination as a multi-layer regulatory network in legume-rhizobium symbiosis.	Plant Cell Rep	2026	https://conductscience.org/library/papers/42053873	PubMed
42,013,603	Manipulation of nonclassical ubiquitin signaling by pathogenic bacteria.	Curr Opin Microbiol	2026	https://conductscience.org/library/papers/42013603	PubMed
41,926,452	Specificity and recognition of the ADP-ribosyl-ubiquitin modification in the DNA damage response.	PLoS Biol	2026	https://conductscience.org/library/papers/41926452	PubMed
41,884,348	E3 ubiquitin ligases: structural diversity, dysregulation in disease, and their emerging role in targeted therapeutic strategies.	Front Mol Biosci	2026	https://conductscience.org/library/papers/41884348	PubMed

1 to 10 of 49

See all 49 cited by

Genes58

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes	Source
ACAT2	39	PubTator's text mining	https://conductscience.org/library/genes/39	NCBI Gene
ARIH1	25,820	PubTator's text mining	https://conductscience.org/library/genes/25820	NCBI Gene
ART3	419	PubTator's text mining	https://conductscience.org/library/genes/419	NCBI Gene
AXIN1	8,312	PubTator's text mining	https://conductscience.org/library/genes/8312	NCBI Gene
CAT	847	PubTator's text mining	https://conductscience.org/library/genes/847	NCBI Gene
CYLD	1,540	PubTator's text mining	https://conductscience.org/library/genes/1540	NCBI Gene
DTX2	113,878	PubTator's text mining	https://conductscience.org/library/genes/113878	NCBI Gene
DTX3L	151,636	PubTator's text mining	https://conductscience.org/library/genes/151636	NCBI Gene
GABARAPL2	11,345	PubTator's text mining	https://conductscience.org/library/genes/11345	NCBI Gene
GLB1	2,720	PubTator's text mining	https://conductscience.org/library/genes/2720	NCBI Gene

1 to 10 of 58

See all 58 genes

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36200073

GET https://conductscience.org/api/papers/v1/36200073/references?page=2

API reference For AI assistants